Praveen Advani, Janssen Pharmaceuticals
Praveen Advani, Commercial Insights & Strategy Lead Solid Tumor Oncology, Janssen Pharmaceuticals
Praveen Advani has more than 24 years of demonstrated leadership in US & Global pharmaceutical commercial excellence leading multiple cross functional teams to shape & influence strategic decisions. Praveen is currently the Commercial Insights & Strategy Lead Solid Tumor Oncology at Janssen Pharmaceuticals. In this role, Praveen is responsible to lead the commercial excellence efforts (market research, forecasting, analytics) for the Solid Tumor Oncology Portfolio in the US providing actionable insights to drive strategy and impact decisions to achieve business goals
Praveen has been instrumental in successfully leading US & Global market research teams for several major global launches, most recently as the Executive Director for WW Immuno-Oncology at Bristol-Myers Squibb where he was responsible for leading all the US and International market research efforts to help successfully launch one of the fastest growing brands in the industry – Opdivo. Prior to that, he has successfully led the market research efforts for Januvia/Janumet (Diabetes, Merck) and Lantus (Diabetes, Aventis/Sanofi)
Praveen holds a MBA from Thunderbird, The American Graduate School of International Management and a Bachelors degree in Engineering from the University of Pune, India.
Lisa Courtade, Organon
Lisa Courtade, Executive Director, Commercial Assessment, Insights & Analytics, Organon
A strategic, solutions oriented business leader with over 20 years of success in delivering customer insights that drive business results, Lisa has a passion for the healthcare industry and for the patients we serve. Lisa was an early adopter of engaging patients in marketing research and leveraging CPG methodologies in the pharma space which contributed to receipt of the ARF’s David Ogilvy Award for creative use of insights in celebrate breakthrough moments when creative inspiration and research insights come together to produce a spectacular advertising campaign.
Lisa lives her passion for shaping the future of the industry by serving on the Marketing Research Institute International Board (MRII) as Chair of the Pharma Curriculum Committee and as an Advisory Board & Steering Committee member for the University of Georgia’s Masters in Marketing Research program, where she also serves as an alumni mentor. Lisa is an active member of the Healthcare Businesswoman’s Association (HBA) where she chaired Career Development and served as the first Global Research Director.
Sandipa Dublish, SpringWorks Therapeutics
Sandipa Dublish, VP, Commerical Data, Advanced Analytics, Insights, SpringWorks Therapeutics
Sandipa Dublish is a Commercial Strategy leader in biopharmaceuticals. She has extensive experience in new product development, launch strategy, portfolio/M&A assessments. Her career history includes large and small biopharmaceuticals with a focus in oncology and rare diseases. Sandipa holds a Ph.D. in Marketing from Florida International University, Miami.
Ronald Flandro, Merck
Ronald Flandro, Associate Director Market Research, Merck
Ron has over 18 years of experience in the pharmaceutical industry in various roles including: hospital sales, managed care contracting and analytics, and market research in several therapeutic areas. He is a global professional with both US and Global Experience. As an Associate Director at Merck, his current primary focus is on hospital products. He has also led qualitative, quantitative, primary and secondary market research for business development opportunities, in-line and launch brands.
Stuart Greenberg, Bayer
Stuart Greenberg, Director, Customer and Business Insights Oncology, Bayer
Dr. Stuart E. Greenberg is currently Director, Customer and Business Insights Oncology at Bayer. His responsibilities include qualitative and quantitative primary research, secondary research, forecasting and market size and structure analysis. In the past he has been on the Global Market Research teams of Pfizer, Pharmacia, Searle, Roche Diagnostics and Boehringer Mannheim. Stuart has managed market research on cancer treatment and prevention drugs, blood glucose monitors, point of care testing equipment and ophthalmic instruments. Stuart earned his undergraduate degree from Lafayette College and achieved a Masters and PhD in Industrial/Organizational Psychology at Virginia Tech.
Ken Kirsch, AstraZeneca
Ken Kirsch, Customer Insights Lead, AstraZeneca
Ken Kirsch is a tenured and broadly skilled pharmaceutical market insights professional with experience in retail, specialty and oncology markets. Ken started his career as a syndicated market research, competitive intelligence and consulting lead at Scott-Levin. Ken then moved to the manufacturer side of the industry, where he has led US and Global market insights for specialty and retail therapies at Wyeth, GSK, Jazz, and now AstraZeneca. Ken is currently a Customer Insights Lead for AstraZeneca’s Diabetes Franchise. At Wyeth, Ken led the research integration effort for the company’s emerging hematology/oncology franchise. At GSK, he led global market research, forecasting and data analytics across the company’s oncology franchise. At Jazz, he led US market research for the company’s first retail launch.
Ken Kirsch is a tenured and broadly skilled pharmaceutical market insights professional with experience in retail, specialty and oncology markets. Ken started his career as a syndicated market research, competitive intelligence and consulting lead at Scott-Levin. Ken then moved to the manufacturer side of the industry, where he has led US and Global market insights for specialty and retail therapies at Wyeth, GSK, Jazz, and now AstraZeneca. Ken is currently a Customer Insights Lead for AstraZeneca’s Diabetes Franchise. At Wyeth, Ken led the research integration effort for the company’s emerging hematology/oncology franchise. At GSK, he led global market research, forecasting and data analytics across the company’s oncology franchise. At Jazz, he led US market research for the company’s first retail launch.
Ken holds an MBA in Pharmaceutical and Healthcare Marketing from Saint Joseph’s University in Philadelphia. He also sits on the Advisory Board of the Pharmaceutical Market Research Conference. Ken lives in Collegeville, PA with his wife Patty. Their daughters Hannah and Elizabeth attend the University of Pittsburgh and University of Delaware, respectively. In his spare time, Ken enjoys playing with his two English Springer Spaniels, Ollie and Finley, and volunteering (but not performing) with Methacton Community Theater.
Richard McCloud, Pfizer
Richard McCloud, Director, Business Analytics and Insights, Pfizer
Rich McCloud is a Director, Business Analytics and Insights, supporting the Pediatric Vaccines Business.
Rich has over 20 years of consulting experience, providing decision support across multiple therapeutic areas, and high priority brands such as Celebrex, Lyrica, Cymbalta, Xolair, biosimilars, and tanezumab. His experience includes a strong history in launching prime mover products and preparing for new competitors.
Rich started his career in pharmaceutical consulting at ZS Associates and moved to Pfizer in 2001. His first position was on Celebrex, where he was responsible for supporting the HCP launch. He launched the Lyrica fibromyalgia indication before moving to Genentech, where he gained biologics and medical benefit reimbursement experience working on Xolair. He also has DTC experience from working on the very successful Cymbalta DTC campaigns in both chronic pain and depression indications.
Rich returned to New York and Pfizer in 2009 to work on Lyrica. He moved to the Biosimilars team in 2013, and supported global launch of Inflectra, and three Oncology Biosimilar assets for Herceptin, Rituxan, and Avastin. Most recently, Rich worked on Tanezumab where he led groundbreaking initiatives on performance measurement, scenario planning for new competitors, and finding new opportunities within patient journey.
Rich earned a bachelor’s degree in Business Administration from Florida A&M University, and a Master’s degree from the University of Georgia. In his (spare?) time, Rich and Tanya continually chase, encourage, and celebrate their four children (Gabrielle (15), Hendrix (11), Lillian (10), and Maxwell (5).
Mini Pinto, Merck
Mini Pinto, Executive Director, Global Market Research & Analytics, Oncology Franchise, Merck
Mini Pinto – Executive Director Brand Strategy & Operations, responsible for Market Research & Analytics for Global Oncology at Merck Pharmaceuticals. Passionate about innovation, brand strategy and “Thinking outside the box”. Working for the largest Pharma Brand, Keytruda – Mini’s single minded focus is to get drugs out to the patients in the fastest possible way. Mini is a key supporter of the MR industry and routinely presents at conferences, webinars and MR events. Mini has lived and worked across Asia, Europe and the US and is a great supporter of cultural variances as well as Diversity & Inclusion.
Grace Samoil Reynolds, Bristol-Myers Squibb
Grace Samoil Reynolds, Senior Director Customer Insight Immunology, Bristol-Myers Squibb
Grace is Senior Director Customer Insight Immunology at Bristol-Myers Squibb. She was previously at Johnson & Johnson where she joined in 1997 in the Market Research Department at Personal Products (consumer). She then progressed through roles in Market Research and Forecasting management in the Pharmaceutical Sector, including responsibility for Women’s Health, Urology and Pain at Ortho McNeil. Most recently, she was responsible for Market Research and Forecasting for the CNS and Pain Franchises in early Pharmaceutical Development. She also has experience in Oncology, Anemia, Metabolics, and Mens Health. Prior to J&J, Grace worked at Schering Plough and Colgate Palmolive, primarily in a Market Research capacity.
Grace earned her MBA at Rutgers University in New Jersey and holds a Bachelors in Chemistry from McGill University, Montreal, Canada. Her passion is driving innovation and future thinking.
David Rosen, Purdue Pharmaceuticals
David Rosen, Head of Analytics, Market Access and Pricing, Purdue Pharmaceuticals
David currently leads the Forecasting, Analytics and Market Research group at Purdue. David began his career at Purdue 13 years ago as a Forecasting Manager but soon worked his way up into significant additional responsibilities. Prior to joining Purdue, he was a consultant at Easton Associates, an international consulting firm specializing in product and business strategy for companies in the life sciences industries. There David led opportunity assessments, due diligence analyses and go to market strategies for numerous novel pharmaceutical therapies, medical devices and diagnostic tests. David began his pharmaceutical career at Bristol Myers Squibb, where he was selected to participate in their management development program.
David holds a Bachelor of Arts in Psychology from Cornell University. In addition, he holds a Masters of Business Administration in Healthcare Finance and Strategy and a Masters of Public Health with honors, both from Yale University.
Jeet Uppal, Bristol-Myers Squibb
Jeet Uppal, Worldwide Lead – Global Market Research Capabilities, Bristol-Myers Squibb
Jeet is currently the Worldwide Lead, Market Research Capabilities & Enablement at Bristol-Myers Squibb. He leads a team of Researchers and his group responsibilities include managing tracking studies across all therapeutic areas and regions, social listening, MR agency management, knowledge management, training and best practice. Earlier he also established and led the oncology patient chart audit at BMS.
Prior to BMS, Jeet was the Global Group Director for Global Market Research at Zoetis. Jeet led a global team of market researchers and was responsible for Market Research across all species, regions and new products. Jeet joined Pfizer in 2003 as Director, Global Market Research. Pfizer spun off to Zoetis in 2012.
Jeet worked in Pfizer Human Pharmaceutical Opthalmology and Oncology disease areas. He led Pfizer Opthalmology’s market research US and worldwide teams for Glaucoma (Xalatan & Xalacom), Macular degeneration (Macugen) and New Products (Dry eye, DME, strategic evaluation of new disease areas and licensing/development opportunities). Prior to moving to Animal Health, Jeet worked in Pfizer’s Oncology TA and led market research for Oncology New Products and Business Development.
Prior to joining Pfizer, Jeet worked for 10 years in marketing and market research at premier companies including Procter & Gamble, PepsiCo International and Reliant Energy. Jeet started his market research career at Procter & Gamble, where he led core projects across P&G’s Paper, Home-Care and New Ventures business units. Jeet has led market research efforts on multiple billion dollar plus brands like Bounty, Luvs, Pampers, Cascade and Dawn, leading both established business and new ventures. Jeet led PepsiCo’s international market research for the core Pepsi brands. At Reliant Energy, Jeet led direct marketing and market research for the deregulating utility market.
Jeet received his MBA from University of Chicago with specialization in strategy and finance. He holds a Masters in Environmental Engineering from Pennsylvania State University.